SHH and melanoma: To confirm the clinical relevance of ligand-dependent mechanism of Hh cascade activation in melanoma, we performed immunoenzymatic quantification of the Shh ligand in the serum of a panel of 58 melanoma patients compared to healthy control subjects (n = 50).